Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB vs TOLVAPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOCILIZUMAB vs TOLVAPTAN: Safety Overview

Metric TOCILIZUMAB TOLVAPTAN
Total FAERS Reports 98,443 9,014
Deaths Reported 9,543 1,709
Death Rate 9.7% 19.0%
Hospitalizations 24,039 2,467
Average Patient Age 52.2 yrs 56.2 yrs
% Female Patients 84.5% 52.0%
FDA Approval Date N/A Apr 23, 2018
Manufacturer CELLTRION USA, Inc. Otsuka America Pharmaceutical, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription